The contribution of fibroblasts to innate immune protection of the human female reproductive tract (FRT) against viral pathogens is relatively unknown. 
| INTRODUC TI ON
The immune system in the female reproductive tract (FRT) is adapted to protect against incoming pathogens, while accommodating the needs of reproduction. 1 Stromal fibroblasts are the predominant cell population in the sub-epithelial layers of the FRT mucosa where they regulate tissue architecture, epithelial proliferation and barrier permeability. [2] [3] [4] [5] In pre-menopausal women with normal menstrual cycles, the endometrial (EM) epithelium is cyclically shed at menstruation, exposing the underlying fibroblasts to the external environment and incoming pathogens. Furthermore, sexually transmitted viral pathogens such as HIV can cross the epithelial barrier to infect immune cells that reside in an environment dominated by fibroblasts. 6 Thus, it is important to define the role of fibroblasts in host defense which is poorly understood. Currently, they are not considered to be active participants in the innate immune response to pathogens in the FRT. Defining their role in immune protection will be essential in furthering women's reproductive health.
Pattern recognition receptors (PRR) are essential for the recognition of conserved pathogen-associated molecular patterns 8, a neutrophil chemo-attractant, as well as regulated on activation, normal T cell expressed and secreted (RANTES), a lymphocyte and monocyte chemo-attractant. 9, 10 Our own group has demonstrated that poly (I:C), a synthetic dsRNA viral ligand recognized by multiple PRRs (TLR3, RIG-I and MDA5), 11, 12 induces the secretion of IL-27 13 and hepatocyte growth factor (HGF) 14 by EM fibroblasts.
The cyclic changes of the sex hormones estradiol (E 2 ) and progesterone (P) during the menstrual cycle in pre-mennopausal women regulate the multiple components of the FRT immune system. 1,15 E 2 , acting via estrogen receptor (ER) α and β, is a key modulation of immune function in the FRT. 1, 15 Previous studies have shown that cytokine and chemokine expression by EM fibroblasts are under hormonal control as demonstrated by E 2 -mediated inhibition of monocyte chemotactic protein 1 (MCP-1) expression and stimulation of HGF, stromal-derived factor 1α (SDF-1α), IL-13 and IL-15 expression. 14, [16] [17] [18] Further, our studies have shown that E 2 selectively regulates the response to TLR agonists in different cell types in the FRT [19] [20] [21] [22] including EM fibroblasts. 13 Despite these observations, little is known about how E 2 regulates the antiviral response of stromal fibroblasts throughout the FRT.
In this study, we demonstrate that stromal fibroblasts from different sites in the FRT mount an immune response to the viral ligand poly 
| Isolation of stromal fibroblasts
Stromal fibroblasts were isolated as previously described. 23 Briefly, FRT tissues were minced into 1-2-mm fragments under sterile conditions and digested using an enzyme mixture contain- 
| Cell culture
Freshly isolated stromal fibroblasts and immune cells were incubated in complete medium in a T75 cell culture flask (ThermoFisher, Logan, UT) as previously described. 24 Briefly, media was replaced 
| Estradiol and raloxifene treatment
17β-Estradiol (E 2 ) (Calbiochem, Gibbstown, NJ) or the selective estrogen receptor modulator raloxifene hydrochloride (Rx) (Tocris Biosciences, Bristol, UK) 26 were dissolved in 100% ethanol for an initial concentration of 1 × 10 −3 mol/L, evaporated to dryness in a glass scintillation vial and resuspended to a concentration of 1 × 10 −5 mol/L in complete media containing charcoal dextran-stripped FBS as previously described. 20 Further dilutions were made to achieve final working concentrations of E 2 ranging from 5 × 10 −8 to 5 × 10 −10 mol/L. These values are representative of E 2 concentrations detected in the human FRT at specific stages of the menstrual cycle and are distinct from those values reported in the peripheral circulation. [27] [28] [29] [30] [31] [32] As a control, an equivalent amount of ethanol without dissolved hormone was initially evaporated.
For E 2 inhibition experiments, as described previously, 33 Rx was added at 100-fold excess (5 × 10 −6 mol/L) 1 hour prior to addition of E 2 and maintained in cell culture till the conclusion of the experiment.
| Measurement of cytokines and antimicrobials
Cell culture-conditioned media was analyzed by ELISA for the presence of RANTES, IL-6, TNFα, IL-8, CCL20, MCP-1, SDF-1α (all R&D Systems) and IFNβ (PBL Assay Science) according to the manufacturers recommendations.
| Real-time RT-PCR
RNA was isolated and purified using a Qiagen RNeasy Mini Kit for 40 cycles. Gene expression was normalized to β-actin which we have used in previous studies of stromal fibroblasts 13, 14, 24, 34 and whose expression was unaffected by any of the treatments performed in this study. Analysis was conducted using the sequence detection software supplied with the ABI 7300. Relative expression levels were expressed as a fold-increase in mRNA expression and calculated using the formula 2 −ΔΔCt .
| Measurement of anti-HIV activity
HIV-1 strains IIIB (CXCR4-tropic) and BaL (CCR5-tropic) were ob- 
| Statistical analysis
All data analysis was performed using GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA). Statistical tests are described in the figure legends. A P-value <0.05 was considered significantly different.
| RE SULTS

| Characterization of in vitro FRT stromal fibroblast cell cultures
Primary human EM, Cx and ECx stromal fibroblasts were isolated and recovered from enzymatically digested tissues and grown in vitro. Confluent monolayers from the three sites were comparatively similar and composed of thin, long and spindle-shaped cells that they originate from stroma functionalis rather than the stroma basalis. 25 Cell cultures were negative for the pan-leukocyte marker CD45 demonstrating a lack of immune cell contamination in our fibroblast preparations.
| Human FRT fibroblasts express pattern recognition receptors
PRRs are essential for recognition of pathogens and initiation of immune responses. We therefore evaluated the relative expression by 
| Poly (I:C) induces interferon-stimulated gene expression (ISG) via type I IFN signaling in stromal fibroblasts
To determine whether EM fibroblasts are responsive to viral patho- 
| Poly (I:C) induces APOBEC3G expression via TLR3
As poly (I:C) can potentially signal via TLR3, RIG-I or MDA5, 12, 35, 36 we blocked TLR3 signaling using a blocking antibody that we have previously used. 22 While upregulation of APOBEC3G was prevented in the presence of blocking antibody ( Figure 5C ), there was no effect on the induction of MxA and OAS2 in EM fibroblasts ( Figure 5A ,B).
This suggests that ISG expression in response to poly (I:C) is selectively mediated by specific PRRs.
| Estradiol inhibits ISG upregulation in EM but not Cx and ECx fibroblasts
To assess the impact of E 2 on poly (I:C)-mediated signaling, we pretreated EM, Cx and ECx fibroblasts with hormone for 48 hours prior to washout and retreated with hormone in the presence or absence of poly (I:C) for an additional 24 hours. As seen in Figure 6A RIG-I and MDA5 mRNA levels following 48 hours of hormone treatment. However, E 2 had no effect on PRR mRNA expression in EM fibroblasts (data not shown).
| Estradiol increases SDF-1α secretion
As seen in Table 1 , fibroblasts from all three sites constitutively secreted SDF-1α, CCL20, RANTES, MCP-1, IL-8 and IL-6 with no detectable IFNβ or TNFα. SDF-1α was present at highest levels in secretions from EM fibroblasts, while MCP-1, IL-8, IL-6 and CCL20
were highest in secretions from Cx fibroblasts. Except for SDF-1α, the concentration of all cytokines was generally lowest in secretions from EM fibroblasts. There was considerable variability in cytokine and chemokine concentrations between different individuals, possibly due to our samples being obtained from a population of pre-and post-menopausal women and thus across a wide age range.
We next assessed whether E 2 regulated cytokine secretion by stromal fibroblasts. E 2 , either alone or in the presence of poly (I:C), had no effect on the secretion of MCP-1, CCL20, IL-6, IL-
8, RANTES and IFNβ by EM, Cx or ECx fibroblasts (Figure 7).
However, treatment with E 2 significantly increased the secretion of SDF-1α by EM fibroblasts ( Figure 8A ), but not Cx or ECx fibroblasts. To examine the mechanism behind E 2 regulation of SDF-1α, we pre-treated EM fibroblasts with the estrogen receptor (ER) α inhibitor raloxifene (Rx) for 1 hour, prior to the addition of E 2 . As seen in Figure 8B , Rx blocked the upregulation of SDF-1α by E 2 , demonstrating that ERα signaling is essential for increased expression of SDF-1α.
| Stromal fibroblast conditioned media inhibits HIV infection
Previously we found that both EM epithelial cell and ovarian fibroblast conditioned media (CM) contain anti-HIV activity. 34, 37 To Statistical analysis was performed using the non-parametric Wilcoxon signed-rank test F I G U R E 5 TLR3 blockade inhibits APOBEC3G expression. EM stromal fibroblasts were pre-treated with an anti-TLR3 blocking antibody (αTLR3) (20 μg/mL) or isotype control (ISO) for 1 h followed by stimulation with poly (I:C) (25 μg/mL) for 24 h prior to mRNA expression analysis for MxA (A) and OAS2 (B) and APOBEC3G (C) (n = 3). Bars and horizontal lines represent the mean fold-change in mRNA expression ± SEM, respectively, for independent experiments from 3 individual donors with values normalized against the endogenous control β-actin. Statistical analysis was performed using the non-parametric Wilcoxon signed-rank test fibroblasts, in addition to their role as structural cells, are essential in regulating inflammation and immune responses to pathogens and commensal organisms. 38, 39 Together with our studies, this demonstrates that fibroblasts are key mediators of mucosal immunity whose contributions need to be further defined in future studies. were pretreated for 48 h with control media or media containing E 2 , washed out and retreated with E 2 or control media for a subsequent 24 h in the presence or absence of poly (I:C) at 25 μg/ml. After 24 h the total cellular mRNA was recovered and analyzed for changes in gene expression (n = 4). Bars and horizontal lines represent the mean fold change in gene expression ± SEM respectively, for independent experiments with 4 individual donors using matched EM, Cx and ECx, with β-Actin as the endogenous control. Untreated control is set to 1. *P < 0.05, **P < 0.01. Statistical analysis was performed using the non-parametric Wilcoxon Signed Rank test. Notes. Conditioned media from endometrial (EM), endocervical (Cx) and ectocervical (ECx) stromal fibroblasts was collected after 48hr of cell culture and analyzed for secretion of MCP-1, IL-8, IL-6, CCL20, RANTES, and SDF-1α by ELISA. (n = 14). Lower limit of detection: MCP-1 (15.6 pg/ml), IL-8 (31.2 pg/ml), IL-6 (9.38 pg/ml), CCL20 (15.6 pg/ml), RANTES (15.6 pg/ml), SDF-1α (31.2 pg/ml) cells. 19, 43 In the present study, the concentration of SDF-1α but not MCP-1, IL-8, IL-6, CCL20, RANTES, IFNβ and TNFα increased after E 2 treatment of EM fibroblasts. Given that SDF-1α induces the proliferation of Ishikawa uterine epithelial cells, 18 our finding that E 2 stimulates EM fibroblasts production of SDF-1α suggests a mechanism whereby epithelial cells in the endometrium are SDF-1α is also upregulated by E 2 in breast cancer cell lines 45 suggesting that SDF-1α is regulated by E 2 elsewhere in the body.
TA B L E 1 Constitutive cytokine secretion by FRT stromal fibroblasts
Whether E 2 regulates cytokine secretion by fibroblasts at other mucosal sites remains unknown. 57 An unexpected finding in our study was that secretions from E 2 -treated EM fibroblasts reduced IIIB infection of CD4+ T cells but not BaL. One explanation for this finding is that E 2 upregulates SDF-1α, which is known to competitively inhibit viral binding to the CXCR4 co-receptor 58 and thus reduce viral entry into the cell.
Previous studies have shown that fibroblasts can enhance HIV infection of CD4+ T cells in a contact-dependent manner. 59 Together with our study, this suggests distinct contact-independent and dependent contributions by fibroblasts to HIV susceptibility of CD4+
T cells. At present, the contributions of FRT fibroblasts to the overall balance of immune protection against HIV in the FRT remains to be determined. However, it is important to recognize that in vivo extracellular antiviral activity is not the exclusive domain of one cell type, but rather the combined effect of secretions from multiple cell types, including epithelial cells 37, 43 and immune cells.
60
F I G U R E 9 Endometrial stromal fibroblast conditioned media inhibits HIV infection. Conditioned media (CM) was recovered from EM stromal fibroblasts, diluted 1:1 in X-Vivo 15 media and incubated with R5-tropic HIV-1 BaL (A) or X4-tropic HIV-1 IIIB (B) (MOI = 0.1) for 1 h prior to addition to CD4+ T cells for 1 h, followed by extensive washout, and incubation with fresh media. Infection was determined by assessing levels of secreted p24 by ELISA after 7 d. *P < 0.05, **P < 0.01 compared to CM from untreated cells. Bars and horizontal lines represent the percent mean HIV infection ± SEM, respectively, of independent experiments from 6 different individual donors. Statistical analysis was performed using the non-parametric Wilcoxon signed-rank test Therefore, in vivo the contribution of fibroblasts may be a key additive or synergistic component for preventing HIV infection. Charles R. Wira http://orcid.org/0000-0002-7549-3300
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